why choose us

First received: August 11, 2022

Clinical Trial: Implementation of Pre-emptive Pharmacogenomics Testing in Singapore-based Private Hospital Institutions (PPT Study)

Study Status: Completed

Recruit Status: RECRUITING

Condition: Pre-emptive Pharmacogenomics

Study Type: OBSERVATIONAL


Official Title: Implementation of Pre-emptive Pharmacogenomics Testing in Singapore-based Private Hospital Institutions (PPT Study)

Brief Summary: In collaboration with Raffles Medical Group, we will be recruiting 500 patients and following them for the next 3-12 months to see whether pharmacogenomics information provided in the Raffles' Electronic Health Records (EHR) will be used by physicians to personalize patients' prescriptions.

Read more